Statistics
Publications
6
Citations
165
H-Index
6
Active since
2017
Weisong Xu is an author at Nantong University specializing in oncology, medicine, and life sciences.
Publications per year
2017–2024
6
6
The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer
Jie Ji, Minxue Xu, Tianyang Qian et al. · Molecular Biology Reports · 2020 · 29 citations
Medicine, Oncology, Pharmacology +14
Xiaohui Jin, Lan‐Lan Zheng, Meirong Song et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 28 citations
Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis
Dandan Jin, Yujie Jiao, Jie Ji et al. · PeerJ · 2020 · 16 citations · Full text
Medicine, Bioinformatics, Oncology +17
1–5 of 6